A new oral drug for multiple sclerosis has produced promising results in clinical trials. Laquinimod was shown to reduce signs of disease activity in scans, and was well tolerated by patients with the relapsing-remitting form of MS. Experts say an oral medication could potentially be a significant advance, as current drugs are all injectable.
Link to Article
Promising trials for new MS pill - BBC Health News 20th June 2008
Monday, June 23, 2008
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment